Miniaturized ligand binding assays enable scientists to do more with less

Gyros Protein Technologies is driven by a clear mission: to accelerate drug development by miniaturizing ligand binding assays so scientists can do more with less. This focus on productivity and efficiency underpins the development of tools that help researchers overcome challenges such as limited sample volumes and tight timelines. The GyroLab xPlore™ exemplifies this approach, delivering an end‑to‑end workflow in an hour. In this SelectScience interview, hear from Senior Field Application Scientist Eric Feely, as he discusses how the team continues to advance automation technologies and collaborate with automation groups to further streamline and accelerate laboratory workflows.

This video was filmed at SLAS 2026.